Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter

In the news


Explore the latest Leaps investments, news on our companies, thought leadership, and press resources.

In the news

Press Releases


Press coverage of Leaps and portfolio companies


Leaps events


Spotlight on Juergen Eckhardt


Download Image

Juergen Eckhardt is EVP and Head of Leaps by Bayer, the impact investment arm, and Head of Business Development, & Licensing (BD&L) for the Pharmaceuticals division. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than 20 years of experience. He is a strong believer that scientific breakthroughs can help us overcome some of humanity’s biggest challenges, including to cure and prevent chronic disease and to feed an ever-growing world population in a sustainable way – in short: science for a better life. He holds an MD from the University of Basel, Switzerland, and an MBA from INSEAD in Fontainebleau, France.

Read More
Download Image
Juergen leaning against a red brick wall

Op-eds by Juergen Eckhardt


Reports


Explore the latest reports and publications developed by Leaps by Bayer and our collaborators.

  • How Society Feels About Breakthrough Science - Findings Across Generations

    Find out how different generations worldwide feel about breakthrough science in our snapshot report 'How Society Feels About Breakthrough Science: Findings Across Generations’, a collaboration with BCG and market research by IPSOS.

    Download
  • Breakthrough Study USA

    Find out how people in the US feel about breakthrough science in our Breakthrough Study Snapshot Report, a collaboration with BCG and market research by IPSOS.

    Download
  • Breakthrough Study Thumbnail

    Find out how people around the world feel about breakthrough science in our Breakthrough Study, a collaboration with BCG and market research by IPSOS.

    Download
  • thumbnail

    Read about our 2024 milestones, portfolio company highlights, engagement activities, and more.

    Download
  • Thumbnail

    Learn about our custom impact measurement framework WALY and read about the impact magnitude of our portfolio.

    Download
  • LeapsbyBayer Ag Playbook 2024

    Learn how to bring AgTech products from concept to market.

    Download
  • Thumbnail

    Read about our 2023 milestones, portfolio company highlights, engagement activities, and more.

    Download
  • Taking 10 leaps for humanity

    See how our 10 Leaps framework could generate return for humanity.

    Download
  • Annual review 2022

    Read about our 2022 milestones, portfolio company highlights, engagement activities, and more.

    Download

Press Kit


Leaps by Bayer is the impact investment arm of Bayer AG. We invest in teams pursuing fundamental breakthroughs in life science, targeting 10 huge challenges facing humanity.

Some call them impossible. We call them “Leaps”.

  • Press Kit Thumbnail

    Download the latest Press Kit

    Download
  • Juergen

    Juergen Eckhardt Photo

    Download
  • Juergen

    Juergen Eckhardt Photo

    Download

Media Contact


Kira Peikoff

Kira Peikoff is a former journalist who covered emerging biotechnologies for publications including The New York Times, Newsweek, and Popular Mechanics. She now leads communications for Leaps by Bayer.

Get in touch
https://leaps.bayer.com/Kira-Peikoff-profile-image-2.webp

Our return
to humanity

The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.

Explore Our Team
  • 01-20-2025

    Leaps by Bayer Publishes Breakthrough Study in Collaboration with BCG

    Read
  • 01-13-2025

    BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial

    Read
  • 10-24-2024

    Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program

    Read
  • 05-28-2024

    Bayer advances genome-editing initiatives for nutrition enhanced vegetables

    Read
  • 02-13-2024

    Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M

    Read
show more
  • March 18, 2025

    These 10 biotech companies are changing how we discover new drugs and treat complex diseases

    Fast Company
  • March 10, 2025

    For Patients Needing Transplants, Hope Arrives on Tiny Hooves

    The New York Times
  • March 05, 2025

    This Gates-backed startup can fine-tune plants for specific purposes—without ever touching their genes

    Fast Company
  • February 03, 2025

    F.D.A. Approves Studies of Pig Organ Transplants for Kidney Patients

    The New York Times
  • November 19, 2024

    The 4 next big technologies in food and agriculture for 2024

    Fast Company
  • September 26, 2024

    Endpoints 11 winner Capstan Therapeutics: Trying to win the in vivo CAR-T race

    Endpoints News
Show More

July 2023

Tech Open Air Berlin

Details

March 2023

World Agri Tech Summit

Details

March 2023

SXSW

Details

January 2023

JPM Healthcare Conference

Details

November 2022

MIT EmTech

Details

September 2022

Bayer Media Event

Details

April 2022

SynBioBeta

Details

November 2021

The New York Times Climate Hub at COP26

Details

October 2019

Boston HubWeek

Details

November 2017

Summit LA

Details
More Events
  • May 29, 2025

    Forbes Logo

    Jennifer Doudna: A Multi-Billion Dollar Market For CRISPR Therapies Is Possible

    Read More
  • April 23, 2025

    Forbes Logo

    Treating Autoimmune Diseases: Four New Technologies To Watch

    Read More
  • March 18, 2025

    Forbes Logo

    Emerging Breakthroughs In Diabetes Treatment: A New Era Of Hope

    Read More
  • February 18, 2025

    Forbes Logo

    New Global Survey Reveals Mixed Attitudes Toward Breakthrough Tech

    Read More
  • January 16, 2025

    Forbes Logo

    5 Insights From The 2025 JP Morgan Healthcare Conference

    Read More
  • December 19, 2024

    Forbes Logo

    5 Important Medical Breakthroughs Of 2024

    Read More
Show More